Stellus Capital Investment Corp annual report, FY2023

Stellus Capital Investment Corporation — 2023 Form 10-K

Reporting period: Fiscal year ended December 31, 2023. This is an annual filing, not a standalone fourth-quarter report. Stellus is an externally managed BDC that lends primarily to U.S. middle-market companies, with debt and related equity investments.

Financial and portfolio highlights

Metric20232022
Investment income$105.8 million$75.1 million
Operating expenses, net of fee waivers$63.6 million$46.5 million
Net investment income$42.2 million; $1.92 per share$28.6 million; $1.46 per share
Net increase in net assets from operations$17.5 million; $0.80 per share$14.5 million; $0.74 per share
Realized investment gain (loss)$(30.2) million$3.7 million
Net unrealized appreciation (depreciation) on investments and currency$2.8 million$(17.5) million
Distributions per share$1.61$1.30
Year-end net asset value per share$13.26$14.02
Cash and cash equivalents$26.1 million$48.0 million
  • Investment income rose mainly with portfolio growth and higher rates. Net investment income increased, but higher interest expense, management fees, and incentive fees also raised expenses.
  • Realized losses of $30.2 million, principally on certain debt investments, offset the increase in investment income. The unrealized result improved from 2022, primarily reflecting realizations of investments previously written down.
  • The portfolio’s fair value was $874.5 million across 93 companies, versus $844.7 million across 85 companies a year earlier. Cost was $902.1 million. First-lien debt represented 88.6% of fair value, second-lien debt 2.5%, unsecured debt 0.7%, and equity 8.2%.
  • Debt-investment weighted-average yield was 11.9%, including approximately 11.0% current cash interest; yield across all investments was 11.1%. These are portfolio yields before company and subsidiary fees and expenses, not shareholder returns.
  • Four portfolio-company loans were on non-accrual, equal to 4.2% of loan cost and 1.3% of loan fair value; the comparable fair-value figure was 2.3% in 2022. Unaccrued income on non-accrual investments was $7.5 million.
  • Portfolio ratings showed 86% of fair value in categories 1 and 2, 12% in category 3, and 2% in categories 4 and 5. Category 5 investments totaled $6.8 million at fair value.
  • Business services was the largest industry exposure at 23.78% of portfolio fair value; healthcare and pharmaceuticals was 11.77%, and high-tech industries 10.52%. Texas and California were the largest state exposures.

Debt, liquidity, and cash flow

  • Year-end debt principal included $160.1 million outstanding under the revolving Credit Facility, $325.0 million of SBA-guaranteed debentures, and $100.0 million of 4.875% notes due 2026. The balance sheet reports debt net of unamortized financing costs.
  • Asset coverage was 223%, up from 192% in 2022; the BDC statutory minimum is 150%. The company reported compliance with Credit Facility covenants, including a $10 million minimum liquidity test, 1.67:1 minimum asset coverage, and 1.75:1 minimum interest coverage.
  • The Credit Facility has $260 million of committed capacity, subject to borrowing-base and other conditions; it matures in 2028, with the commitment to borrow ending in November 2027. Its year-end weighted-average interest rate was 7.9%, versus 4.4% in 2022. SBA debentures have fixed rates; their weighted-average rate was 3.2%.
  • Operating activities used $17.3 million of cash in 2023, mainly reflecting investment purchases net of repayments and sales. Financing activities used $4.7 million, primarily for distributions and net Credit Facility repayments, partly offset by ATM proceeds. Cash declined by $21.9 million.
  • Unfunded commitments were approximately $37.0 million at year-end, including $36.7 million of debt and $0.3 million of equity commitments. Management said cash and available Credit Facility borrowings were sufficient to meet them.
  • Interest-rate sensitivity analysis estimated that a 100-basis-point increase would increase annual net interest income by $6.4 million, while a 100-basis-point decrease would reduce it by $6.4 million, assuming the balance sheet stayed constant. The filing cautions that actual effects may differ.

Material changes, outlook, and risks

  • Compared with 2022, investment income and net investment income increased, and portfolio fair value grew. However, realized results shifted from a $3.7 million gain to a $30.2 million loss, while year-end NAV per share fell by $0.76.
  • During 2023, Stellus issued 4.46 million shares through its ATM program for $62.9 million gross proceeds, primarily to repay Credit Facility borrowings. The average issuance price was $14.10 per share. The filing reports 24,125,642 shares outstanding at year-end.
  • Management described economic activity as accelerating but cited supply-chain interruptions, labor shortages, commodity inflation, rising rates, bank impairments, geopolitical conflict, sanctions, and market instability. It gave no specific earnings or portfolio-growth guidance.
  • The Board declared monthly distributions of $0.1333 per share for January, February, and March 2024. Management said it intended to continue comparable distributions, but payment remains subject to Board discretion, earnings, liquidity, BDC requirements, and debt covenants.
  • Key risks include credit deterioration and defaults among leveraged borrowers; valuation uncertainty for illiquid, predominantly Level 3 investments; rate and funding-cost changes; leverage and collateral claims; liquidity and refinancing risk; and the ability to maintain RIC and BDC status. PIK and other accrued noncash income can create distribution needs before the related cash is received.
  • The SEC below-NAV issuance authorization approved in 2023 covers up to 25% of outstanding shares and expires at the earlier of the 2024 annual meeting or June 22, 2024. The filing warns that below-NAV issuance could dilute existing shareholders.
  • Grant Thornton issued an unqualified opinion on the financial statements and identified valuation of investments as a critical audit matter. Management concluded disclosure controls and internal control over financial reporting were effective as of year-end; the auditor was not engaged to opine on internal control effectiveness.
  • The company reported no material pending legal proceedings. It reported no cybersecurity incident known to have materially affected, or reasonably likely to materially affect, the company as of the filing date, while warning that future incidents could have material effects.

Most important facts for investors to verify

  • Review the realized-loss detail and portfolio-company financial condition, especially the loans on non-accrual and investments with large write-downs. For example, the control investment in EH Real Estate Services had $17.3 million cost and $6.2 million fair value at year-end.
  • Assess the assumptions supporting fair values: all reported portfolio investments were Level 3, and the auditor highlighted valuation estimates as a critical audit matter.
  • Check current Credit Facility usage, borrowing-base availability, covenant headroom, and the timing and cost of debt maturities; distinguish principal outstanding from carrying values net of fees.
  • Evaluate whether recurring cash income supports distributions, given the $1.61 per-share distribution against $1.92 per-share net investment income, realized losses, noncash accruals, and the company’s leverage.
  • Review the effects of the 2023 ATM issuance on NAV per share and ownership dilution, and confirm the status of below-NAV issuance authority after its stated expiration.